UPDATE : Tuesday, October 15, 2019
상단여백
Qurient sets up joint firm with Nobel chemistry prize winner by Lee Han-soo 2019-10-04 17:45
Lilly's Verzenio extends life for women with advanced breast cancer by Lee Han-soo 2019-10-04 16:15
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit by Lee Han-soo 2019-10-02 16:10
CDK4/6 inhibitor+fulvestrant combo nears getting benefit by Kim Yun-mi 2019-10-02 16:03
Daewoong's EU partner wins sales approval for BTX by Lee Han-soo 2019-10-02 14:51
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment by Lee Han-soo 2019-10-01 16:43
Drugmakers’ illegal rebates down, support for doctors up by Kwak Sung-sun 2019-10-01 13:49
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment by Lee Han-soo 2019-10-01 11:21
‘Merck Korea unilaterally lays off employees’ by Kim Yun-mi 2019-10-01 11:09
Allergan to compensate breast implant recipients for damage by Lee Hye-seon 2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals by Jeong Sae-im 2019-09-30 15:16
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months by Lee Hye-seon 2019-09-30 11:25
Investor trust in bio-industrialists sank due to latter’s unethical acts by Lee Han-soo 2019-09-27 15:11
Genexine sets up joint firm in Thailand by Lee Han-soo 2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question by Lee Han-soo 2019-09-26 15:39
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit by Kim Yun-mi 2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients' by Lee Han-soo 2019-09-25 17:39
Huons, Lipac Oncology to co-develop bladder cancer treatment by Lee Han-soo 2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor by Lee Han-soo 2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment by Lee Han-soo 2019-09-24 17:00
여백
여백
여백
Back to Top